NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Iris Energy Limited (“Iris” or the “Company”) (NASDAQ: IREN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
Month: August 2024
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Caribou Biosciences, Inc. (“Caribou” or the “Company”) (NASDAQ: CRBU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Agenus Inc. (“Agenus” or the “Company”) (NASDAQ: AGEN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of General Motors Company (“GM” or the “Company”) (NYSE: GM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Coinbase Global, Inc. (“Coinbase” or the “Company”) (NASDAQ: COIN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of MaxLinear, Inc. (“MaxLinear” or the “Company”) (NASDAQ: MXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of STMicroelectronics N.V. (“ST” or the “Company”) (NYSE: STM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…